GHP Investment Advisors’s Integra LifeSciences IART Stock Holding History

GHP Investment Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20	Closed	-$440	–	983
2025 Q1	$440	Hold	20	–	–	﹤0.01%	913
2024 Q4	$454	Hold	20	–	–	﹤0.01%	946
2024 Q3	$363	Sell	20 -67,662	-100%	-$1.57M	﹤0.01%	941
2024 Q2	$1.97M	Buy	67,682 +2,498	+4%	+$74.1K	0.1%	221
2024 Q1	$2.31M	Buy	65,184 +7,460	+13%	+$298K	0.11%	214
2023 Q4	$2.51M	Buy	57,724 +4,928	+9%	+$194K	0.14%	204
2023 Q3	$2.02M	Buy	52,796 +167	+0.3%	+$7.03K	0.12%	206
2023 Q2	$2.3M	Buy	52,629 +6,349	+14%	+$306K	0.13%	207
2023 Q1	$2.66M	Buy	46,280 +2,244	+5%	+$126K	0.17%	180
2022 Q4	$2.47M	Sell	44,036 -7,804	-15%	-$397K	0.17%	184
2022 Q3	$2.2M	Buy	51,840 +7,609	+17%	+$390K	0.17%	190
2022 Q2	$2.39M	Buy	44,231 +15,956	+56%	+$958K	0.18%	182
2022 Q1	$1.82M	Buy	+28,275	New	+$1.86M	0.12%	215

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GHP Investment Advisors's IART Position: Q2 2025 in Review

GHP Investment Advisors sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 20 shares — an estimated $440 sold.

GHP Investment Advisors first reported a position in IART in Q1 2022 and held it in 13 quarters. The position peaked at $2.66M in Q1 2023. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

GHP Investment Advisors reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
GHP Investment Advisors sold 20 Integra LifeSciences shares in Q2 2025, an estimated $440.
GHP Investment Advisors first reported a position in Integra LifeSciences in Q1 2022 and held it in 13 quarters.
GHP Investment Advisors's Integra LifeSciences position peaked at $2.66M in Q1 2023.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on GHP Investment Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.